{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:06:59Z","timestamp":1747998419948},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T00:00:00Z","timestamp":1129766400000},"content-version":"vor","delay-in-days":5406,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[1991,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We evaluated four commercially available ELISAs for detection of antibody to Borrelia burgdorferi with 21 sera from patients with clinically diagnosed Lyme disease and 89 patient control sera. Patient control sera included 28 sera from patients with rheumatoid arthritis (RA), 17 sera from patients with systemic lupus erythematosus (SLE), and 44 sera containing antibodies reported to crossreact in some Lyme disease tests. The ELISAs tested (Cambridge Bioscience, Diamedix, 3M, and Zeus) detect antibodies (IgM and\/or IgG) that bind Borrelia burgdorferi antigen attached to microtiter wells. Antibody reactivity in the sera from patients with clinically diagnosed Lyme disease was characterized by using Zeus immunoglobulin class\u2010specific assays (IgM and IgG). Sensitivities in early and late Lyme disease were as follows: Cambridge and Diamedix, 57% and 100%; 3M, 57% and 93%; and Zeus, 71% and 86%. Reactivities within a patient control population were: Cambridge and Diamedix, 3%; 3M, 7%; and Zeus, 10%.<\/jats:p>","DOI":"10.1002\/jcla.1860050509","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T20:06:19Z","timestamp":1173125179000},"page":"340-343","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of four commercially available elisa assays for the serologic diagnosis of lyme disease"],"prefix":"10.1002","volume":"5","author":[{"given":"Vicki D.","family":"Christenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane H.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,20]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/jcm.20.2.181-184.1984","article-title":"Comparison of an indirect fluorescent\u2010antibody test with an enzyme\u2010linked immunosorbent assay for serological studies of Lyme disease","volume":"20","author":"Magnarelli LA","year":"1984","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548609032330"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.6.1325"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1128\/jcm.27.12.2834-2837.1989","article-title":"Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum","volume":"27","author":"Fister RD","year":"1989","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_6_2","first-page":"s17","article-title":"The 1987 revised ARA criteria for rheumatoid arthritis","volume":"30","author":"Arnett FC","year":"1987","journal-title":"Arth Rheum"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.4.790"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303313081301"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65506-2"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-99-1-76"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90432-2"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/159.1.43"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-90-6-896"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.6.1018"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.27.1.58-61.1989"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcla.1860050509","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.1860050509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:48:28Z","timestamp":1698022108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.1860050509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,1]]}},"alternative-id":["10.1002\/jcla.1860050509"],"URL":"https:\/\/doi.org\/10.1002\/jcla.1860050509","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,1]]}}}